TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression

Yang, Li, Pang, Yanli, Moses, Harold L.·2010·Trends in Immunology
DOI 10.1016/j.it.2010.04.002

Cited by (1,000)

Items 101–200 of 1,000

  1. Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas
    Cindy Neuzillet, Armand D.E. Gramont, Annemilaï Tijeras‐Raballand, Louis de Mestier, Jerome F. Cros, Sandrine J. Faivre, Éric Raymond · 2013 · Oncotarget
  2. IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis
    Charles Kisali Pallangyo, Paul K. Ziegler, Florian R. Greten · 2015 · The Journal of Experimental Medicine
  3. Utilizing Cytokines to Function-Enable Human NK Cells for the Immunotherapy of Cancer
    Rizwan Romee, Jeffrey W. Leong, Todd A. Fehniger · 2014 · Scientifica
  4. Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer
    Shaobo Yang, Binquan Wang, Guan Chunying, Benyan Wu, Changhao Cai, Mengwei Wang, Binsheng Zhang, Tao Liu, Ping‐Chang Yang · 2010 · Journal of Leukocyte Biology
  5. Tumour microenvironment responsive nanoconstructs for cancer theranostic
    Arif Gulzar, Jiating Xu, Chen Wang, Fei He, Dan Yang, Shili Gai, Piaoping Yang, Jun Lin, Dayong Jin, Bengang Xing · 2019 · Nano Today
  6. Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers
    Limei Shen, Jingjing Li, Qi Liu, Wantong Song, Xueqiong Zhang, Karthik Tiruthani, Haiyang Hu, Manisit Das, Tyler J. Goodwin, Rihe Liu et al. · 2018 · ACS Nano
  7. Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy
    David S. Schweer, Annabel M. McAtee, Khaga Raj Neupane, Christopher I. Richards, Frederick R. Ueland, Jill Kolesar · 2022 · Cancers
  8. Genetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of Combination Immunotherapy
    Iyer, Sonia, Zhang, Shuang, Yucel, Simge, Horn, Heiko, Smith, Sean G., Reinhardt, Ferenc, Hoefsmit, Esmee, Assatova, Bimarzhan, Casado, Julia, Meinsohn, Marie-Charlotte et al. · 2021 · Cancer Discovery
  9. Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma
    Eric S. Yvon, Rachel A. Burga, Allison B. Powell, Carolina Colli Cruz, Rohan Fernandes, Cecilia N. Barese, Tuongvan Nguyen, Mohamed Shebl Abdelbaki, Catherine M. Bollard · 2017 · Cytotherapy
  10. Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications
    Jessica P Roelands, Peter J.K. Kuppen, Louis Vermeulen, Cristina Maccalli, Julie V. Decock, Ena Wang, Francesco Maria Marincola, Davide Bedognetti, Wouter Hendrickx · 2017 · International Journal of Molecular Sciences
  11. Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy
    Zhe Fu, Alexandra M. Mowday, Jeff Bruce Smaill, Ian F. Hermans, Adam Vorn Patterson · 2021 · Cells
  12. The Next Generation of Immunotherapy for Cancer: Small Molecules Could Make Big Waves
    Kerr, William G, Chisholm, John D · 2019 · The Journal of Immunology
  13. Combinatorial prospects of nano-targeted chemoimmunotherapy
    Candido G. Da Silva, Félix Rueda, Clemens W.G.M. Löwik, FERRY A. OSSENDORP, Luis Javier Cruz · 2016 · Biomaterials
  14. TGF‑β signaling: A complex role in tumorigenesis (Review)
    Shuang Liu, Shuang Chen, Jun Zeng · 2017 · Molecular Medicine Reports
  15. The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions
    Alberta Bergamo, Paul J. Dyson, Gianni Sava · 2018 · Coordination Chemistry Reviews
  16. New Approaches on Cancer Immunotherapy
    Jong‐Ho Cha, Li-Chuan Chan, Min Sup Song, Mien‐Chie Hung · 2019 · Cold Spring Harbor Perspectives in Medicine
  17. Maternal Soluble Fiber Diet during Pregnancy Changes the Intestinal Microbiota, Improves Growth Performance, and Reduces Intestinal Permeability in Piglets
    Chuanshang Cheng, Hongkui Wei, Chuanhui Xu, Xiaowei Xie, Siwen Jiang, Jian Peng · 2018 · Applied and Environmental Microbiology
  18. Mechanisms of tumor escape from immune system: Role of mesenchymal stromal cells
    Alessandro Delli Poggi, Alessandra Musso, Irene Dapino, Maria Raffaella Zocchi · 2014 · Immunology Letters
  19. Transforming growth factor-beta 1 delivery from microporous scaffolds decreases inflammation post-implant and enhances function of transplanted islets
    Jeffrey Mao-Hwa Liu, Jesse Zhang, Xiaomin Zhang, Kelan A. Hlavaty, Christine F. Ricci, Joshua N. Leonard, Lonnie D. Shea, Robert Michael Gower · 2015 · Biomaterials
  20. Nanoparticles for tumor immunotherapy
    Xinlong Zang, Xiuli Zhao, Haiyang Hu, Mingxi Qiao, Yihui Deng, Dawei Chen · 2017 · European Journal of Pharmaceutics and Biopharmaceutics
  21. Molecular Pathways: Targeting the Microenvironment of Liver Metastases
    Simon Milette, Jason Keith Sicklick, Andrew M. Lowy, Pnina Brodt · 2017 · Clinical Cancer Research
  22. Clinical Application of Cytokines in Cancer Immunotherapy
    Yi Qiu, Mengxi Su, Leyi Liu, Yiqi Tang, Yuan Pan, Jianbo Sun · 2021 · Drug Design Development and Therapy
  23. Cancer-associated fibroblasts: Vital suppressors of the immune response in the tumor microenvironment
    Xuan Xiang, Yiran Niu, Zi-Hao Wang, Linlin Ye, Wenbei Peng, Qiong Zhou · 2022 · Cytokine & Growth Factor Reviews
  24. Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment
    Yang, Xue, Li, Qing, Liu, Wenting, Zong, Chen, Wei, Lixin, Shi, Yufang, Han, Zhipeng · 2023 · Cellular & Molecular Immunology
  25. A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells
    Shota Warashina, Takashi Nakamura, Yusuke Sato, Yuki Fujiwara, Mamoru Hyodo, Hiroto Hatakeyama, Hideyoshi Harashima · 2016 · Journal of Controlled Release
  26. Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
    Bin Han, Fang-yuan Mao, Yongliang Zhao, Yi-pin Lv, Yong‐sheng Teng, Mubing Duan, Weisan Chen, Ping Cheng, Tingting Wang, Zhong-Yuan Liang et al. · 2018 · Journal of Immunology Research
  27. Roles of TGF-β signaling pathway in tumor microenvirionment and cancer therapy
    Haodi Zhao, Jing Wei, Jian M. Sun · 2020 · International Immunopharmacology
  28. Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment
    Brown, Nicholas F., Marshall, John F. · 2019 · Cancers
  29. Orchestration of Angiogenesis by Immune Cells
    Antonino Bruno, Arianna Pagani, Laura Pulze, Adriana Albini, Katiuscia Dallaglio, Douglas McClain Noonan, Lorenzo Mortara · 2014 · Frontiers in Oncology
  30. Antifibrotic therapy to normalize the tumor microenvironment
    Anette Hauge, Einar K. Rofstad · 2020 · Journal of Translational Medicine
  31. Turning tumors from cold to inflamed to improve immunotherapy response
    Camille Lea Gerard, Julie Delyon, Alexandre M. Wicky, Krisztián Homicskó, Michel A. Cuendet, Olivier Alain Michielin · 2021 · Cancer Treatment Reviews
  32. Lactobacillus plantarum PFM 105 Promotes Intestinal Development Through Modulation of Gut Microbiota in Weaning Piglets
    Tian-Wei Wang, Kun-Ling Teng, Ya-Yong Liu, Weixiong Shi, Jie Zhang, En-Qiu Dong, Xin Zhang, Yong Tao, Jin Zhong · 2019 · Frontiers in Microbiology
  33. Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models
    Heng Sheng Sow, Jiang Ren, Marcel G M Camps, FERRY A. OSSENDORP, Peter ten Dijke · 2019 · Cells
  34. HGF/MET and the Immune System: Relevance for Cancer Immunotherapy
    Papaccio, Federica, Della Corte, Carminia Maria, Viscardi, Giuseppe, Di Liello, Raimondo, Esposito, Giovanna, Sparano, Francesca, Ciardiello, Fortunato, Morgillo, Floriana · 2018 · International Journal of Molecular Sciences
  35. How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
    Alessandro Delli Poggi, Serena Varesano, Maria Raffaella Zocchi · 2018 · Frontiers in Immunology
  36. Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets
    Zhangfeng Zhong, Chi Teng Vong, Feiyu Chen, Horyue Tan, Cheng Zhang, Ning Wang, Liao Cui, Yitao Wang, Yibin Feng · 2022 · Medicinal Research Reviews
  37. Human Fetal Liver Mesenchymal Stem Cell-Derived Exosomes Impair Natural Killer Cell Function
    Yé Fan, Florence Herr, Amélia Vernochet, Benoit Mennesson, Estelle Oberlin, Antoine Dürrbach · 2018 · Stem Cells and Development
  38. The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability
    Arya Mariam Roy, Renuka V. Iyer, Sayan Chakraborty · 2023 · Cell Reports Medicine
  39. IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors
    Heba A Alshaker, Khalid Z. Matalka · 2011 · Cancer Cell International
  40. Targeting the Microenvironment in Advanced Colorectal Cancer
    Daniele V. F. Tauriello, Eduard Batlle · 2016 · Trends in cancer
  41. Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance
    Midrar AlHossiny, Linlin Luo, William R. Frazier, Noriko Steiner, Yuriy Gusev, Bhaskar Kallakury, Eric F. Glasgow, Karen M. Creswell, Subha Madhavan, Rakesh Kumar et al. · 2016 · Cancer Research
  42. Ultrathin Metal-Organic-Layer Mediated Radiotherapy-Radiodynamic Therapy
    Kaiyuan Ni, Guangxu Lan, Christina Chan, Xiaopin Duan, Nining Guo, Samuel S. Veroneau, Ralph R. Weichselbaum, Wenbin Lin · 2019 · Matter
  43. Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy
    Soundararajan, Rama, Fradette, Jared, Konen, Jessica, Moulder, Stacy, Zhang, Xiang, Gibbons, Don, Varadarajan, Navin, Wistuba, Ignacio, Tripathy, Debasish, Bernatchez, Chantale et al. · 2019 · Cancers
  44. Liver transplantation
    Manuel Rodríguez‐Perálvarez, Manuel de la Mata, Andrew Kenneth Burroughs · 2014 · Current Opinion in Organ Transplantation
  45. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment
    Peng Qu, Lizhen Wang, P. Charles Lin · 2015 · Cancer Letters
  46. TGF-β Superfamily Signaling in the Eye: Implications for Ocular Pathologies
    Soumaya Hachana, Bruno Larrivée · 2022 · Cells
  47. Targeting of cancer-associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment
    Minmin Li, Mei Li, Tao Yin, Shi H, YUAN WEN, Binglan Zhang, Meihua Chen, Guangchao Xu, Kexin Ren, Yuquan Wei · 2016 · Molecular Medicine Reports
  48. Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity
    Paramita Chakraborty, Silvia G. Vaena, Krishnamurthy Thyagarajan, Shilpak Chatterjee, Amir A. Al-Khami, Shanmugam Panneer Selvam, Hung Dang Nguyen, In‐Hong Kang, Megan W. Wyatt, Uday K. Baliga et al. · 2019 · Cell Reports
  49. Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response
    Ben S. Sidders, Pei Zhang, Kelly Goodwin, Greg O’Connor, Deanna L. Russell, Alexandra Borodovsky, Joshua Armenia, Robert K. McEwen, Bolan Linghu, Johanna C. Bendell et al. · 2020 · Clinical Cancer Research
  50. Local Release of TGF‐ β Inhibitor Modulates Tumor‐Associated Neutrophils and Enhances Pancreatic Cancer Response to Combined Irreversible Electroporation and Immunotherapy
    Huiming Peng, Jian Shen, Xin Long, Xiaoqi Zhou, Jiaqi Zhang, Xina Xu, Teng Huang, Hui Xu, Shuguo Sun, Chun Li et al. · 2022 · Advanced Science
  51. SMAD4 promotes TGF-β–independent NK cell homeostasis and maturation and antitumor immunity
    Youwei Wang, Jianhong Chu, Ping Yi, Wejuan Dong, Jennifer N. Saultz, Yufeng Wang, Hongwei Wang, Steven D. Scoville, Jianying Zhang, Lai‐Chu Wu et al. · 2018 · Journal of Clinical Investigation
  52. The human lymph node microenvironment unilaterally regulates T-cell activation and differentiation
    Konstantin Knoblich, Sara Cruz Migoni, Susan Siew, Elizabeth Jinks, Baksho Kaul, Hannah C. Jeffery, Alfie T. Baker, Muath Suliman, Katerina Vrzalikova, Hisham Mehenna et al. · 2018 · PLoS Biology
  53. The involvement of multifunctional TGF-β and related cytokines in pathogenesis of endometriosis
    Justyna Sikora, Marta Smycz‐Kubańska, Aleksandra Mielczarek‐Palacz, Ilona Anna Bednarek, Zdzisława Kondera‐Anasz · 2018 · Immunology Letters
  54. Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy
    Keishi Adachi, Koji Tamada · 2015 · Cancer Science
  55. Transcriptome meta-analysis reveals differences of immune profile between eutopic endometrium from stage I-II and III-IV endometriosis independently of hormonal milieu
    Omero Benedicto Poli‐Neto, Juliana Meola, Júlio César Rosa e Silva, Daniel Guimarães Tiezzi · 2020 · Scientific Reports
  56. Alternative RNA splicing and cancer
    Sali Liu, Chonghui Cheng · 2013 · Wiley Interdisciplinary Reviews - RNA
  57. Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
    Madyson Colton, Eleanor J. Cheadle, Jamie Honeychurch, Tim Illidge · 2020 · Radiation Oncology
  58. Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer
    Ling Cai, Hongyu Liu, Fang Huang, Junya Fujimoto, Luc Girard, Jun Chen, Li Y, Yu-An Zhang, Dhruba Deb, Victor Stastny et al. · 2021 · Communications Biology
  59. Emerging impact of the long noncoding RNA MIR22HG on proliferation and apoptosis in multiple human cancers
    Le Zhang, Cuixia Li, Xiulan Su · 2020 · Journal of Experimental & Clinical Cancer Research
  60. Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting
    Antonella Sistigu, Francesca Di Modugno, Gwenola Manic, Paola Nisticò · 2017 · Cytokine & Growth Factor Reviews
  61. Tumor-derived TGF-β inhibits mitochondrial respiration to suppress IFN-γ production by human CD4 + T cells
    Sarah Dimeloe, Patrick M. Gubser, Jordan Loeliger, Corina Frick, Leyla Develioglu, Marco Fischer, Florian A. Marquardsen, Glenn R. Bantug, Daniela S. Thommen, Yannic Lecoultre et al. · 2019 · Science Signaling
  62. The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance
    Renee B. Chang, Gregory Lawrence Beatty · 2020 · Journal of Leukocyte Biology
  63. Exploiting temporal aspects of cancer immunotherapy
    Rachael M. Zemek, Valsamo Anagnostou, Inês Pires da Silva, Georgina Venetia Long, Willem Joost Lesterhuis · 2024 · Nature reviews. Cancer
  64. Dynamic aberrant NF-κB spurs tumorigenesis: A new model encompassing the microenvironment
    Spiros Vlahopoulos, Osman Çen, Nina Hengen, JAMES E. AGAN, Maria A. Moschovi, Elena Critselis, Maria Adamaki, Flora Bacopoulou, John Alton Copland, Istvan R. Boldogh et al. · 2015 · Cytokine & Growth Factor Reviews
  65. Shaping the repertoire of tumor‐infiltrating effector and regulatory T cells
    Peter Aidan Savage, Daniel S. Leventhal, Sven Malchow · 2014 · Immunological Reviews
  66. Innate Antiviral Host Defense Attenuates TGF-β Function through IRF3-Mediated Suppression of Smad Signaling
    Pinglong Xu, Samantha L. Bailey-Bucktrout, Ying Xi, Daqi Xu, Dan Du, Qian Zhang, Weiwen Xiang, Jianming Liu, Andrew C. Melton, Dean Sheppard et al. · 2014 · Molecular Cell
  67. Targeting small molecule drugs to T cells with antibody-directed cell-penetrating gold nanoparticles
    Yu-Sang Sabrina Yang, Kelly Dare Moynihan, Ahmet Bekdemir, Tanmay Dichwalkar, Michelle M. Noh, Nicki Watson, Mariane B. Melo, Jessica R. Ingram, Heikyung Suh, Hidde L. Ploegh et al. · 2018 · Biomaterials Science
  68. CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
    Sasan Ghaffari, Nastaran Khalili, Nima Rezaei · 2021 · Journal of Experimental & Clinical Cancer Research
  69. Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma
    Rachel A. Burga, Eric S. Yvon, Elizabeth A. Chorvinsky, Rohan Fernandes, Carolina Colli Cruz, Catherine M. Bollard · 2019 · Clinical Cancer Research
  70. The impact of hyperglycemia on the corneal epithelium: Molecular mechanisms and insight
    Luke Zhu, Rossella Titone, Danielle M. Robertson · 2019 · The Ocular Surface
  71. Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors
    Denisa Baci, Matteo Gallazzi, Lorenzo Mortara, Annalisa Bosi, Giuseppe Buono, Angelo Naselli, A. Guarneri, Federico Dehò, Paolo Capogrosso, Adriana Albini et al. · 2021 · Frontiers in Immunology
  72. Phase I trial of Seneca Valley Virus (NTX‐010) in children with relapsed/refractory solid tumors: A report of the Children's Oncology Group
    Michael James Burke, Charlotte Hsieh Ahern, Brenda J. Weigel, John Thomas Poirier, Charles M. Rudin, Ying‐Bei Chen, Timothy P. Cripe, Melanie Brooke Bernhardt, Susan M. Blaney · 2014 · Pediatric Blood & Cancer
  73. Dendritic cells with an increased PD-L1 by TGF-β induce T cell anergy for the cytotoxicity of hepatocellular carcinoma cells
    Shasha Song, Pingfan Yuan, Huaxun Wu, Jingyu Chen, Jingjing Fu, Peipei Li, Jingtao Lu, Wei Wei · 2014 · International Immunopharmacology
  74. TIGIT promotes CD8+T cells exhaustion and predicts poor prognosis of colorectal cancer
    Rongpu Liang, Xudong Zhu, Tianyun Lan, Dongbing Ding, Zongheng Zheng, Tufeng Chen, Yong Lin Huang, Jianpei Liu, Xiaofeng Yang, Jun Shao et al. · 2021 · Cancer Immunology Immunotherapy
  75. Enhanced Cancer Immunotherapy with Smad3-Silenced NK-92 Cells
    Qing-Ming Wang, Patrick Ming‐Kuen Tang, Guang‐Yu Lian, Chunjie Li, Jinhong Li, Xiao‐Ru Huang, Ka‐Fai To, Hui Y. Lan · 2018 · Cancer Immunology Research
  76. Combination of Asiatic Acid and Naringenin Modulates NK Cell Anti-cancer Immunity by Rebalancing Smad3/Smad7 Signaling
    Guang‐Yu Lian, Qingming Wang, Patrick Ming‐Kuen Tang, Shuang Ying Zhou, Xiao‐Ru Huang, Hui-Yao Lan · 2018 · Molecular Therapy
  77. Tumour immunotherapy: lessons from predator–prey theory
    Phineas T. Hamilton, Bradley R. Anholt, Brad H. Nelson · 2022 · Nature reviews. Immunology
  78. CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ
    Hangyi H. Yan, Jian Dong Jiang, Yanli Pang, B.R. Achyut, Michael M. Lizardo, Xin‐hua Liang, Kent W. Hunter, Chand Khanna, Christine M. Hollander, Yang Li · 2015 · Cancer Research
  79. The tumor microenvironment in prostate cancer: elucidating molecular pathways for therapy development
    Paul Gettys Corn · 2012 · Cancer Management and Research
  80. Optimize and refine therapeutic index in radiation therapy: Overview of a century
    Cyrus Chargari, Nicolas Magné, Jean‐Baptiste Guy, C. Rancoule, Antonin Lévy, Karyn A. Goodman, Éric Deutsch · 2016 · Cancer Treatment Reviews
  81. The immune suppressive function of transforming growth factor-β(TGF-β) in human diseases
    Jingyi Sheng, Weisan Chen, Hong‐Jian Zhu · 2015 · Growth Factors
  82. Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy
    Shuyan Han, Keqing Huang, Zhipeng Gu, Jun Wu · 2019 · Nanoscale
  83. Targeting regulatory T cells
    Christine Ménétrier‐Caux, Tyler Jay Curiel, Julien Faget, Manuarii Manuel, Christophe Caux, Weiping Zou · 2012 · Targeted Oncology
  84. TGF-β of lung cancer microenvironment upregulates B7H1 and GITRL expression in dendritic cells and is associated with regulatory T cell generation
    XIAO YAN NI, Hua Xiu Sui, Yao Liu, Shi Zhong Ke, Yi Nan Wang, FENG GUANG GAO · 2012 · Oncology Reports
  85. Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties
    Novitskiy, Sergey V, Pickup, Michael W, Chytil, Anna, Polosukhina, Dina, Owens, Philip, Moses, Harold L · 2012 · Journal of Leukocyte Biology
  86. The peritumor microenvironment: physics and immunity
    Sue Zhang, Kathryn Regan, Julian Najera, Mark W. Grinstaff, Meenal Datta, Hadi Tavakoli Nia · 2023 · Trends in cancer
  87. Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses
    Amir Dashti, Marzieh Ebrahimi, Jamshid Hadjati, Arash Memarnejadian, Seyed Mohammad Moazzeni · 2016 · Cancer Letters
  88. Immune response drives outcomes in prostate cancer: implications for immunotherapy
    Jialin Meng, Yujie Zhou, Xiaofan Lu, Zichen Bian, Yiding Chen, Song Fan, Jun Zhou, Li Zhang, 郝宗耀, Meng Zhang et al. · 2020 · Molecular Oncology
  89. Role of TLR2‐dependent inflammation in metastatic progression
    Sun-Hwa Kim, Michael Karin · 2011 · Annals of the New York Academy of Sciences
  90. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy
    Silvia Gaggero, Kristina Witt, Mattias Carlsten, Suman Mitra · 2021 · Frontiers in Immunology
  91. Adipose progenitor cells increase fibronectin matrix strain and unfolding in breast tumors
    Emily M. Chandler, M P Saunders, Christine J. Yoon, Delphine Gourdon, Claudia Fischbach · 2011 · Physical Biology
  92. TGF-�1 Promotes Osteosarcoma Cell Migration and Invasion Through the miR-143-Versican Pathway
    Fengfeng Li, Shaohua Li, Cheng Tao · 2014 · Cellular Physiology and Biochemistry
  93. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling
    Guoliang Dai, Bingting Sun, Tao Gong, Zihao Pan, Qinghai Meng, Wenzheng Ju · 2018 · Phytomedicine
  94. Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer
    Ryoichi Katsube, Kazuhiro Noma, Toshiaki Ohara, Noriyuki Nishiwaki, Teruki Kobayashi, Satoshi Komoto, Hiroaki Sato, Hajime Kashima, Takuya Kato, Satoru Kikuchi et al. · 2021 · Scientific Reports
  95. Cutting to the Chase: How Matrix Metalloproteinase-2 Activity Controls Breast-Cancer-to-Bone Metastasis
    Marilena Tauro, Conor C. Lynch · 2018 · Cancers
  96. Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer
    Paul H. van der Horst, Yongyi Wang, Ingrid Vandenput, Liesbeth C. Kühne, Patricia C. Ewing, Wilfred F. J. van IJcken, Marten van der Zee, Frédéric C. Amant, Curt W. Burger, Leen J. Blok · 2012 · PLoS ONE
  97. Gr‐1+CD11b+ cells are responsible for tumor promoting effect of TGF‐β in breast cancer progression
    Zhaoyang Li, Yanli Pang, Sudheer Kumar Gara, Bhagelu R. Achyut, Christopher D. Heger, Paul K. Goldsmith, Scott M. Lonning, Howard Hua Yang · 2012 · International Journal of Cancer
  98. Osteosarcoma cells promote the production of pro-tumor cytokines in mesenchymal stem cells by inhibiting their osteogenic differentiation through the TGF-β/Smad2/3 pathway
    Bing Tu, Zhaoxiang Peng, Qiming Fan, Lin Du, Wei Yan, Tingting Tang · 2013 · Experimental Cell Research
  99. Uterine double-conditional inactivation of Smad2 and Smad3 in mice causes endometrial dysregulation, infertility, and uterine cancer
    Maya L. Kriseman, Diana Monsivais, Julio E. Agno, Ramya P. Masand, Chad J. Creighton, Martin Matthew Matzuk · 2019 · Proceedings of the National Academy of Sciences
  100. Anticancer natural medicines: An overview of cell signaling and other targets of anticancer phytochemicals
    Muhammad Furqan Akhtar, Ammara Saleem, Azhar Rasul, Mirza Muhammad Faran Ashraf Baig, May Nasser Bin-Jumah, Mohamed M. Abdel‐Daim · 2020 · European Journal of Pharmacology